Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Y0ZQ
|
|||
Former ID |
DIB012444
|
|||
Drug Name |
Ecabapide
|
|||
Synonyms |
Ecabamide; Muralis; DQ-2511
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Peptic ulcer [ICD-11: DA61] | Discontinued in Preregistration | [1] | |
Company |
Daiichi Seiyaku Co Ltd
|
|||
Structure |
Download2D MOL |
|||
Formula |
C20H25N3O4
|
|||
Canonical SMILES |
CNC(=O)C1=CC(=CC=C1)NCC(=O)NCCC2=CC(=C(C=C2)OC)OC
|
|||
InChI |
1S/C20H25N3O4/c1-21-20(25)15-5-4-6-16(12-15)23-13-19(24)22-10-9-14-7-8-17(26-2)18(11-14)27-3/h4-8,11-12,23H,9-10,13H2,1-3H3,(H,21,25)(H,22,24)
|
|||
InChIKey |
JTAGHJPZEDNHHA-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 104775-36-2
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adrenergic receptor alpha-2C (ADRA2C) | Target Info | Modulator | [2] |
KEGG Pathway | cGMP-PKG signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Panther Pathway | Alpha adrenergic receptor signaling pathway | |||
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Reactome | Adrenoceptors | |||
Adrenaline signalling through Alpha-2 adrenergic receptor | ||||
Adrenaline,noradrenaline inhibits insulin secretion | ||||
G alpha (i) signalling events | ||||
G alpha (z) signalling events | ||||
Surfactant metabolism | ||||
WikiPathways | Monoamine GPCRs | |||
GPCRs, Class A Rhodopsin-like | ||||
Platelet Aggregation (Plug Formation) | ||||
Integration of energy metabolism | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000582) | |||
REF 2 | Identification of major biliary and urinary metabolites of ecabapide in rats. Xenobiotica. 1996 Sep;26(9):983-94. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.